ADVANCED/METASTATIC NSCLC
Clinical trials for ADVANCED/METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new ADVANCED/METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for ADVANCED/METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two-Pronged attack: engineered immune cells target tough lung cancers
Disease control Recruiting nowThis study is testing a new type of cell therapy for people with advanced non-small cell lung cancer that has stopped responding to standard treatments. Doctors will give patients specially engineered immune cells (called CAR-NK cells) designed to recognize and attack two specifi…
Matched conditions: ADVANCED/METASTATIC NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Cancer treatment breakthrough? timing your therapy could be key
Disease control Recruiting nowThis study is testing whether giving standard immunotherapy in the morning versus the afternoon makes it work better for patients with advanced cancer. It will enroll 350 people with advanced lung cancer or other solid tumors who are starting immunotherapy for the first time. Par…
Matched conditions: ADVANCED/METASTATIC NSCLC
Phase: PHASE2 • Sponsor: Liza Villaruz, MD • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC